Compare Johnson & Johnson (JNJ) vs Lowe`s Companies Inc (LOW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs Lowe`s Companies Inc — how do they compare? Johnson & Johnson trades at $259.62 (market cap $618.09B), while Lowe`s Companies Inc trades at $184.85 (market cap $105.96B). The key difference: Johnson & Johnson is far larger — about 5.8× Lowe`s Companies Inc's market cap, and Lowe`s Companies Inc pays the higher dividend (2.65%). Which is the better fit depends on your goals — on Pluang, investors hold Johnson & Johnson for 129 Days and Lowe`s Companies Inc for 98 Days on average.
| JNJ | LOW | |
|---|---|---|
Market Cap | $618.09B | $105.96B |
Volume | 6,050,983 | 4,039,547 |
Sector | Health | Consumer Cyclical |
52-Week High | $278.43 | $287.39 |
52-Week Low | $186.00 | $179.50 |
Typical Hold Time | 129 Days | 98 Days |
Enterprise Value | $646.37B | $144.81B |
Dividend Yield | 2.09% | 2.65% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $258.45, up 1.44% with a bearish technical signal despite recent earnings beats. The company maintains strong fundamentals with $94.19B revenue, 21.48% net margin, and robust cash flow. Analyst consensus is bullish with a $286.53 price target, though technical indicators show resistance near $260. Recent news highlights pipeline strength including Icotyde's potential $4.5B peak sales.
JNJ offers stable dividend income and pharmaceutical innovation upside, but faces patent cliff risks and competitive pressures. The stock presents value near current levels with 10.7% upside to consensus target, though technical weakness suggests potential near-term consolidation. Long-term growth drivers include oncology portfolio and Ottava surgical system development.
Lowe's (LOW) trades at $181.54, down 1.17% on the day, with a bearish technical signal and recent price weakness amid a slowing home improvement market. The company has beaten earnings estimates for the last three quarters, with a P/E of 15.96 and net income margin of 7.35%. Recent news highlights drone delivery tests with DoorDash and Alphabet, while cash flow improved in 2025 but is projected to decline in 2026.
The stock offers value with a consensus price target of $244.09, implying 34% upside, supported by a 60.79% buy rating from analysts. Risks include high debt levels, competitive pressure from Home Depot, and sensitivity to housing market trends. The current technical setup suggests near-term support at $179, with potential for a rebound if fundamentals hold.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About Lowe`s Companies Inc
Lowe's is the second-largest home improvement retailer in the world, operating 1,969 stores and servicing around 230 dealer-owned stores throughout the United States and Canada. The firm's stores offer products and services for home decorating, maintenance, repair, and remodeling, with maintenance and repair accounting for two thirds of products sold. Lowe's targets retail do-it-yourself (around 75% of sales) and do-it-for-me customers as well as commercial and professional business clients (around 25% of sales). We estimate Lowe's captures a low-double-digit share of the domestic home improvement market, based on U.S. Census data and management's estimates for market size.
Read more on LOW →
